ArticleOral radiology2026
Imaging findings of basaloid squamous cell carcinoma: a case report.
Article in Oral radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Basaloid squamous cell carcinoma (BSCC) is a rare, high-grade variant of SCC. In the oral cavity, BSCC predominantly originates from the floor of the mouth and base of the tongue and is characterized by aggressive behavior, with frequent nodal and distant metastases. To date, no case has comprehensively reported BSCC findings across multiple imaging modalities in a single patient. A 78-year-old male presented with persistent erythema, swelling, and pain in the anterior mandible. Clinical examination revealed exposed bone with an exophytic soft tissue mass and cutaneous fistula. The lesion was initially suspected to represent osteoradionecrosis following prior management of SCC (pT1N0M0) with laser resection, neck dissection, and radiotherapy. However, disease recurrence could not be excluded. Panoramic radiography showed an ill-defined radiolucency in the anterior mandible. CT revealed a 55 × 20 × 48 mm inhomogeneously enhancing mass with associated bone destruction and extending to the skin. MRI demonstrated alveolar and labial cortical bone destruction, with soft tissue component isointense to muscle on T1-weighted images and heterogeneous high signal on T2-weighted and T1-weighted contrast enhanced images. PET-CT showed high FDG uptake (SUVmax: 17.2) without nodal or distant metastasis. Biopsy findings were suggestive of BSCC, which was confirmed by histopathologic examination of the resected lesion. This report highlights the utility of multimodal imaging in lesion characterization and supporting clinical decision-making, while the histopathological examination remains the gold standard for the definitive diagnosis. It also underscores the importance of vigilant follow-up in patients with oral BSCC for early detection of local recurrence and distant metastases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.